Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High density and proximity of CD8+ T cells to tumor cells are correlated with better response to nivolumab treatment in metastatic pleural mesothelioma.
Yin Y, Sakakibara R, Honda T, Kirimura S, Daroonpan P, Kobayashi M, Ando K, Ujiie H, Kato T, Kaga K, Mitsumura T, Nakano R, Sakashita H, Matsuge S, Ishibashi H, Akashi T, Hida Y, Morohoshi T, Azuma M, Okubo K, Miyazaki Y. Yin Y, et al. Among authors: sakashita h. Thorac Cancer. 2023 Jul;14(20):1991-2000. doi: 10.1111/1759-7714.14981. Epub 2023 May 30. Thorac Cancer. 2023. PMID: 37253418 Free PMC article.
Treatment of advanced lung cancer based on genomic profiling using liquid biopsy (plasma): A review of three cases.
Mitsumura T, Kumaki Y, Takahashi K, Matsudera S, Sakakibara R, Honda T, Ishizuka M, Iijima Y, Shirai T, Okamoto T, Tateishi T, Sakashita H, Miyake S, Ikeda S, Miyazaki Y. Mitsumura T, et al. Among authors: sakashita h. Thorac Cancer. 2021 Sep;12(18):2508-2512. doi: 10.1111/1759-7714.14098. Epub 2021 Aug 10. Thorac Cancer. 2021. PMID: 34378333 Free PMC article.
A phase II feasibility study of carboplatin and nab-paclitaxel for advanced non-small cell lung cancer patients with interstitial lung disease (YLOG0114).
Sakashita H, Uchibori K, Jin Y, Tsutsui T, Honda T, Sakakibara R, Mitsumura T, Nukui Y, Shirai T, Masuo M, Suhara K, Furusawa H, Yamashita T, Ohba T, Saito K, Takagiwa J, Miyashita Y, Inase N, Miyazaki Y. Sakashita H, et al. Thorac Cancer. 2022 May;13(9):1267-1275. doi: 10.1111/1759-7714.14376. Epub 2022 Mar 23. Thorac Cancer. 2022. PMID: 35322551 Free PMC article. Clinical Trial.
Non-inferior clinical outcomes of immune checkpoint inhibitors in non-small cell lung cancer patients with interstitial lung disease.
Tasaka Y, Honda T, Nishiyama N, Tsutsui T, Saito H, Watabe H, Shimaya K, Mochizuki A, Tsuyuki S, Kawahara T, Sakakibara R, Mitsumura T, Okamoto T, Kobayashi M, Chiaki T, Yamashita T, Tsukada Y, Taki R, Jin Y, Sakashita H, Natsume I, Saitou K, Miyashita Y, Miyazaki Y. Tasaka Y, et al. Among authors: sakashita h. Lung Cancer. 2021 May;155:120-126. doi: 10.1016/j.lungcan.2021.03.014. Epub 2021 Mar 22. Lung Cancer. 2021. PMID: 33798901
The utility of ground-glass attenuation score for anticancer treatment-related acute exacerbation of interstitial lung disease among lung cancer patients with interstitial lung disease.
Nishiyama N, Honda T, Sema M, Kawahara T, Jin Y, Natsume I, Chiaki T, Yamashita T, Tsukada Y, Taki R, Miyashita Y, Saito K, Tateishi T, Sakashita H, Miyazaki Y. Nishiyama N, et al. Among authors: sakashita h. Int J Clin Oncol. 2020 Feb;25(2):282-291. doi: 10.1007/s10147-019-01576-x. Epub 2019 Nov 13. Int J Clin Oncol. 2020. PMID: 31720993
237 results